Latest News

 Filter by Provider

Bristol Myers Squibb trades at a fraction of Eli Lilly's valuation while generating substantial free cash flow, but concentration risk and explosive growth tell very different stories.

Sandisk stock has room to run higher even after delivering a multibagger performance in 2026.

This potent exchange-traded fund has significantly outperformed the S&P 500 index.

The storied industrials company just signed a multi-billion-dollar deal with a famous telecom.

An analyst has a new take on this energy stock, and investors aren't impressed.

Karman's director purchased shares at $37.32 each despite a -43% one-year return, bringing his direct stake to 3.5 million shares.

Concentrix (NASDAQ:CNXC) said more than half of its revenue now comes from businesses generated over the past three years, underscoring the company’s shift toward artificial intelligence-enabled services, transformed client programs and newer offerings such as risk and compliance. During its third-

Rivian Automotive (NASDAQ:RIVN) executives said the company is focused on ramping production of its R2 midsize SUV while advancing its in-house autonomy platform toward an initial point-to-point driving rollout late this year. Speaking at an Evercore ISI event, Chip Newcom, Rivian’s vice president

Both stocks may be worth considering for those looking to capitalize on the anti-obesity market.

Oracle regained momentum after last week's force majeure, with 25 new agentic AI applications, today, Sept. 29, 2026.

Innodata offers profitable data engineering with zero debt, while Nebius scales infrastructure at massive cash burn, a fundamental choice between profitability and growth.

The insider disposed of a substantial 10% of her direct equity stake.

Today, Sept. 29, 2026, the battery-swap partnership restructuring weighed on the premium EV maker as traders reassessed profitability ahead of Q3 earnings.

Claiming at your FRA could be the perfect middle ground for some seniors.

On Sept. 29, 2026, cruise demand proved resilient as the operator posted adjusted EPS of $1.43 and $8.44B revenue, beating estimates.

Larsson's open-market acquisition increases his direct stake to roughly 350,000 shares, signaling confidence amid a 12-month period of stock weakness.

Barrick Mining (NYSE:B) said it is working to rebuild its operating credibility through improved safety, consistent guidance delivery, project execution and a planned North American initial public offering, according to remarks from management at a company event. Management said the company had ide

Carnival (NYSE:CCL) reported record third-quarter revenue, yields and net income, with results exceeding its prior guidance as stronger close-in bookings, onboard spending and cost controls offset higher fuel prices. Chief Executive Officer Josh Weinstein said the company generated approximately $2

Uranium Energy (NYSEAMERICAN:UEC) reported a fiscal 2026 production ramp that expanded the company from one operating mine in one state to two mines across Wyoming and Texas, while management outlined further development plans and a strategy to add uranium conversion capacity. Founder and Chief Exe

These dividends should continue to grow, even if the economy falters.

CrowdStrike has pulled further ahead in absolute revenue, but UiPath's seasonal spikes hint at untapped potential.

Customer experience solutions provider Concentrix (NASDAQ:CNXC) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 1.2% year on year to...

The BMO Canadian Money Market ETF (TSX:XMMK) is a great fund for beginners.

GE Vernova remains one of the simplest ways to profit from the AI power boom.

The world's largest chip foundry is bound to benefit as long as heavy AI spending persists.

Discover why Fortis stock is a top portfolio anchor to hold for passive income, no matter what happens to the economy.

Changing credit card rewards show how hard Canadian banks are competing to attract spending and deepen customer relationships.

This under-the-radar property management stock boasts a Superscore of 76 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

AST SpaceMobile trades at a 269x forward P/E versus Firefly's 21.9x, but one faces untested satellite tech while the other depends on government spending.

Dividend investors looking at energy stocks have to walk a fine line, but this trio makes that easy with yields up to 6.7%.

AI data centres need far more than processors, creating opportunities in natural gas and electrical infrastructure.

The name attached to your TFSA could determine how smoothly the account passes to your family after death.

Tesla is expected to announce third-quarter delivery data on Oct. 2.

While Pfizer's dividend looks like a trap, its strong balance sheet and low valuation make it safer.

Potash has neatly dodged the Canada U.S. tariff war so far. Here is why that shield could crack and what it means now for Nutrien stock.

Uncover the power of dividends in your investment strategy, especially in energy stocks amid market uncertainties.

By renting out more compute capacity, SpaceX aims to generate revenue that it can put toward launching orbital data center satellites.

Anthropic will spend $252 billion with these three cloud computing providers.

Hammond Power Solutions stock turned $1,000 into $7,250 in three years, thanks to the AI boom. Is TSX:HPS.A still a buy today?

AI spending doesn't stop with processors as data centres also need electricity, grids, substations, and engineering.

FICO's monopoly on credit scores may be over.

Both companies burn cash and face execution risks, but their valuation gap tells a starkly different story about which deserves your capital.

Coinbase hints at an on-chain Pokemon trading card offering backed by real cards.

What Happened? Shares of financial advisory firm Perella Weinberg Partners (NASDAQ:PWP) jumped 11.9% in the afternoon session after Morningstar reported that...

uniQure (NASDAQ:QURE) reported updated Phase I/II data for its investigational Huntington’s disease gene therapy, ifezuntirgene inilparvovec, or AMT-130, including 36-month results from all high-dose patients and 48-month results from the first 12 high-dose patients to reach that milestone. The com

Not sure whether to max out your TFSA or RRSP first? Your tax bracket holds the answer. Here's how to decide, plus which top TSX stocks suit each account.

This company has increased its dividend annually for more than 30 years.

What Happened? Shares of eyewear retailer Warby Parker (NYSE:WRBY) jumped 10.4% in the afternoon session after the market continued to react to the company’s...